Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - tetanus toxoid; pertactin (69kda outer membrane protein-prn); inactivated polio virus type 1; inactivated polio virus type 2; inactivated polio virus type 3; pertussis toxoid(pt); filamentous haemagglutinin (fha); diphtheria toxoid - suspension for injection - tetanus toxoid (8000024353) 40du; pertactin (69kda outer membrane protein-prn) (8000002317) 8mcg; inactivated polio virus type 1 (8000002316) 40du; inactivated polio virus type 2 (8000002314) 8du; inactivated polio virus type 3 (8000002313) 32du; pertussis toxoid(pt) (8000001811) 25mcg; filamentous haemagglutinin (fha) (8000001813) 25mcg; diphtheria toxoid (8000000804) 30iu - diphtheria-pertussis-poliomyelitis-tetanus

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - measles virus vaccine,live attenuated (schwarz strain); mumps virus vaccine, live; rubella virus vaccine, live attenuated (wistar ra 27/3 strain) - powder & solvent for sol. for inj. in pre-filled syringe - measles virus vaccine,live attenuated (schwarz strain) (8000001266) 0ccid50; mumps virus vaccine, live (8000015998) 0ccid50; rubella virus vaccine, live attenuated (wistar ra 27/3 strain) (8000021478) 0ccid50 - morbilli, comb. w.parotitis & rubella, live attenu

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - mumps virus vaccine, live attenuated(rit 4385 strain); rubella virus vaccine, live attenuated (wistar ra 27/3 strain); measles virus vaccine,live attenuated (schwarz strain); varicella, live attenuated vaccine (oka strain) - powder & solvent for solution for injection - in pre-filled syringe - mumps virus vaccine, live attenuated(rit 4385 strain) (8000001646) 0ccid50; rubella virus vaccine, live attenuated (wistar ra 27/3 strain) (8000021478) 0ccid50; measles virus vaccine,live attenuated (schwarz strain) (8000001266) 0ccid50; varicella, live attenuated vaccine (oka strain) (8000001596) 0pfu - measles,combinations with mumps,rubella and varicella, live attenuated

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

mylan ireland limited (0000011082) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - vancomycin hydrochloride - ΚΟΝΙΣ ΓΙΑ ΕΝΑΙΩΡΗΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 1g/vial - vancomycin hydrochloride (0001404939) 1g - vancomycin

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

mylan ireland limited (0000011082) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - vancomycin hydrochloride - ΚΟΝΙΣ ΓΙΑ ΕΝΑΙΩΡΗΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 500mg/vial - vancomycin hydrochloride (0001404939) 500mg - vancomycin

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - varicella, live attenuated vaccine (oka strain) - powder & solvent for solution for injection - 2000pfu - varicella, live attenuated vaccine (oka strain) (8000001596) 2000pfu - varicella, live attenuated

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

merck sharp & dohme bv (0000009224) waarderweg 39, 2003pc haarlem, 2031 bn, 581 - varicella, live attenuated vaccine (oka strain); vaccinum varicellae vivum - powder & solvent for suspension for injection - 1350 pfu - varicella, live attenuated vaccine (oka strain) (8000001596) 1350pfu; vaccinum varicellae vivum (8000002321) 1350pfu - varicella, live attenuated

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur sa - a/california/7/2009 (h1n1), a/texas/50/2012 (h3n2) b/massachusetts/02/2012 - solution for injection - 8000004241 - a/california/7/2009 (h1n1) - 15 ug; 8000004436 - a/texas/50/2012 (h3n2) - 15 ug; 8000004437 - b/massachusetts/02/2012 - 15 ug - influenza, purified antigen

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - a/guangdong-maonan/swl1536/2019 (h1n1)pdm09-like strain (a/guangdong- maonan/swl1536/2019, cnic-1909); a/hong kong/2671/2019 (h3n2)-like strain (a/hong kong/2671/2019, ivr-208); b/washington/02/2019-like strain (b/washington/02/2019, wild type); b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type) - suspension for injection in pre-filled syringe - 15mcg/dose - a/guangdong-maonan/swl1536/2019 (h1n1)pdm09-like strain (a/guangdong- maonan/swl1536/2019, cnic-1909) (8000004814) 15ug; a/hong kong/2671/2019 (h3n2)-like strain (a/hong kong/2671/2019, ivr-208) (8000004815) 15ug; b/washington/02/2019-like strain (b/washington/02/2019, wild type) (8000004816) 15ug; b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type) (8000004817) 15ug - influenza, purified antigen

Cypern - græsk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

pfizer hellas ae (0000003442) 243 messoghion avenue, neo psychiko, athens, 15451 - tick-borne encephalitis virus - suspension for injection in pre-filled syringe - 0.25ml/dose - tick-borne encephalitis virus (8000004795) 1,19ug